Finance

Beta
Lists
MIRM:BMV
Mirum Pharmaceuticals Inc
MX$1,256.12
-21.09%
(-335.64) 1D
Aug 18, 12:10:03 PM GMT-6  ·   MXN
All symbols
SymbolPriceChange% Change
Generating top insights for MIRM...
Mkt. cap
5.70B
Volume
0.00
52-wk high
MX$1,256.12
52-wk low
MX$948.54
No. of employees
418
Mkt. cap
5.70B
Volume
0.00
52-wk high
MX$1,256.12
52-wk low
MX$948.54
No. of employees
418
News stories
From sources across the web
About Mirum Pharmaceuticals Inc
CEO-
Employees418
Founded2018
HeadquartersFoster City, California, United States
SectorBiotechnology
Websitemirumpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
127.78M
133.01M
148.93M
159.88M
Cost of goods sold
23.42M
25.54M
28.26M
28.80M
Cost of revenue
23.42M
25.54M
28.26M
28.80M
Research and development expenses
46.07M
42.96M
51.11M
97.91M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
63.29M
61.91M
74.13M
96.33M
Operating expense
109.35M
104.87M
125.24M
194.24M
Total operating expenses
132.77M
130.41M
153.50M
223.04M
Operating income
-4.99M
2.60M
-4.57M
-63.16M
Other non operating income
-214.00K
-5.00K
-18.00K
102.00K
EBT including unusual items
-5.46M
2.64M
-4.96M
-789.68M
EBT excluding unusual items
-5.46M
2.64M
-4.96M
-64.38M
Income tax expense
402.00K
-262.00K
767.00K
475.00K
Effective tax rate
-7.36%
-9.91%
-15.45%
-0.06%
Other operating expenses
-
-
-
-
Net income
-5.86M
2.90M
-5.73M
-790.16M
Net profit margin
-4.59%
2.18%
-3.85%
-494.21%
Earnings per share
-0.12
0.05
-0.12
-1.08
Interest and investment income
3.03M
3.25M
3.42M
3.40M
Interest expense
-3.59M
-3.61M
-3.60M
-3.62M
Net interest expenses
-556.00K
-355.00K
-178.00K
-215.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
1.07M
8.66M
1.51M
-56.29M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer